When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
AXNX - Axonics sacral neuromodulation device shows significant treatment benefit in incontinence study
Axonics Modulation Technologies Inc.
Axonics Modulation Technologies (NASDAQ:AXNX)announces positive results from a clinical study, ARTISAN-SNM, evaluating the Axonics r-SNM system in 129 patients with urinary urgency incontinence.
More news on: Axonics Modulation Technologies, Inc., Healthcare stocks news,